drugset
drugset / Trial / NCT05273619

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

NCT05273619 ↗

Phase 3 Completed 250 enrolled Valenta Pharm JSC
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to assess the efficacy and safety of XC8, film-coated tablets, 10 mg in comparison with placebo in patients with dry non-productive cough against acute respiratory infection.

Timeline

Start
2022-05-23
Primary completion
2022-07-13
Completion
2022-07-29

Drugs

EvaluationDrugModalityDoseRoute
Subject XC8 Unknown 40 mg —

Indications

common cold influenza